NetworkNewsBreaks

WednesdayAug 07, 2024 3:39 pm

NetworkNewsBreaks – Match Group Inc. (NASDAQ: MTCH) Quarterly Earnings Report Highlights

Match Group (NASDAQ: MTCH), a leading company in the internet commerce industry, recently reported its quarterly earnings, aligning with the Zacks Consensus Estimate at $0.48 per share, mirroring its performance from the previous year. The company’s revenue for the quarter ending June 2024 was $864.07 million, slightly up from the previous year’s $829.55 million, and exceeded the Zacks Consensus Estimate by 0.92%. This achievement marks the fourth consecutive quarter where Match Group has surpassed consensus revenue estimates, showcasing its consistent performance in a competitive market. Despite these positive earnings reports, Match Group’s stock has seen a decline of about 9% since the…

Continue Reading

WednesdayAug 07, 2024 3:28 pm

NetworkNewsBreaks – Scorpius Holdings Inc. (NYSE American: SCPX) Releases Public Offering Pricing for Public Offering

Scorpius Holdings (NYSE American: SCPX), an integrated contract-development and manufacturing organization (CDMO), has announced the pricing of an underwritten public offering. The offering is comprised of 12,500,000 shares of common stock or prefunded warrants. Each share of common stock or prefunded warrant is offered at $1. According to the announcement, the company has estimated gross proceeds of approximately $12,500,000, before underwriting discounts and offering expenses are deducted; the proceeds will be used for working capital and general corporate expenses. The company also granted the underwriters a 45-day option to purchase up to 1,875,000 additional shares of common stock and/or prefunded…

Continue Reading

WednesdayAug 07, 2024 2:23 pm

NetworkNewsBreaks – SideChannel Inc. (SDCH) Releases Quarterly Report, Notes Second Consecutive Quarter of Positive Cash Flow

SideChannel (OTCQB: SDCH), a leading provider of cybersecurity services and technology to emerging and middle market companies, is reporting its financial results for the three- and nine-month period ended June 30, 2024. Highlights of the report include third-quarter revenue of $1.8 million, year-to-date revenue of $5.5 million, and third-quarter gross margin of 48.9%. The report also showed a decrease in third-quarter operating expenses. In addition, the report indicated revenue retention of 72.3% for the trailing 12 months ended June 30, 2024, with an ending cash balance of $1.1 million at quarter end. The company will be holding a conference call and…

Continue Reading

WednesdayAug 07, 2024 2:01 pm

NetworkNewsBreaks – Iteris Inc. (NASDAQ: ITI) Selected by City of Lakeland to Enhance Road User Safety, Security

Iteris (NASDAQ: ITI), the world’s trusted technology ecosystem for smart mobility infrastructure management, today announced that the City of Lakeland, Florida, has selected it to provide smart mobility infrastructure management technologies to support the city’s Intersection Crash Avoidance Safety Program (“iCASP”). The project includes the deployment of key components of Iteris’ ClearMobility(R) Platform, the world’s most complete solution to monitor, visualize and optimize mobility infrastructure continuously. According to the announcement, the City of Lakeland initiated this project because of the many crashes attributed to red light running in certain high-impact intersections throughout the city. Therefore, the deployment of Iteris’ advanced…

Continue Reading

WednesdayAug 07, 2024 1:31 pm

NetworkNewsBreaks – Nature’s Miracle Holding Inc. (NASDAQ: NMHI) Closes on Public Offering Valued at $1.2M

Nature's Miracle (NASDAQ: NMHI), a growing agriculture-technology company providing equipment and services to growers in the controlled environment agriculture ("CEA") industry, has closed on its previously announced underwritten public offering. The offering was comprised of five million shares of common stock at a public offering price of $0.24 per share. The offering resulted in gross proceeds of $1.2 million, before underwriting discounts and offering expenses were deducted. The underwriter was also granted an option to purchase additional common stock shares of the company and/or warrants. EF Hutton LLC acted as the sole book running manager for the offering.  To view the full press…

Continue Reading

WednesdayAug 07, 2024 1:01 pm

NetworkNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Promotes ‘Invaluable Asset’ to Position of President of Commercial EV Division

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced John Taylor as president of its commercial EV division. In his new role, Taylor will oversee the company’s commercial vehicle operations, including engineering, supply chain management and manufacturing. Taylor, who brings a great breath of experience with a career spanning more than 35 years, also retains his role as senior vice president of global manufacturing for Mullen Automotive. He joined Mullen in 2021 and has played a pivotal role in the development and successful launch of the Mullen ONE Class 1 EV cargo van and Mullen THREE Class…

Continue Reading

WednesdayAug 07, 2024 12:43 pm

NetworkNewsBreaks – Independence Contract Drilling Inc. (NYSE: ICD) Releases Q2 2024 Financial Results

Independence Contract Drilling (NYSE: ICD), a company that provides land-based contract drilling services for oil and natural-gas producers in the United States, is reporting its Q2 2024 financial results for the three-month period ended June 30, 2024. Notable numbers from the report include a net loss of $16.7 million, or $1.15 per share, with adjusted net loss of $10.6 million, or $0.73 per share. Adjusted EBITDA totaled $8.5 million, representing a 28% sequential decrease, with adjusted net debt of $196.7 million, which was a 3% sequential increase. The company also reported that 14.5 average rigs working during the quarter, which was a 4% sequential decrease, with a fully…

Continue Reading

WednesdayAug 07, 2024 12:31 pm

NetworkNewsBreaks – Clene Inc. (NASDAQ: CLNN) Releases Q2 2024 Financial Results, Provides Updates

Clene (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), today released its Q2 2024 financial results. In addition, the company provided recent updates on its CNM-Au8(R) programs evaluating the use of CNM-Au8 for the treatment of ALS and Rett Syndrome. “We are approaching our next FDA interaction focused on the regulatory path forward to potentially bring CNM-Au8 to people living with ALS,” commented Rob Etherington, President and…

Continue Reading

WednesdayAug 07, 2024 12:17 pm

NetworkNewsBreaks – Trump Media & Technology Group (NASDAQ: DJT) Announces ‘Milestone’ Launch of TV Streaming on iOS Devices

Trump Media & Technology Group (NASDAQ: DJT), operator of the social-media platform Truth Social, has added linear TV streaming functionality on iOS devices. According to the announcement, iOS users can update their Truth Social apps through the Apple App Store to access TV streaming. After the app has been updated, they can use the new feature by clicking on the Truth+ streaming icon, which looks like a TV and which enables users to stream content as standalone channels or in a separate picture-in-picture (“PiP”) window while on the Truth Social platform. The addition of streaming on iOS devices is a…

Continue Reading

WednesdayAug 07, 2024 10:40 am

NetworkNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Release Promising Clinical Data As Global Alzheimer’s Disease Therapeutics Market Grows

Annovis Bio (NYSE: ANVS), a late-stage, clinical-drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), has released preclinical data from a study of its lead compound, buntanetap. According to the announcement, the study showed the synergistic effect of buntanetap combined with the glucagon-like peptide 1 (GLP-1) agonist dulaglutide (Trulicity[R]) in enhancing cognition in a mouse model of Alzheimer’s disease. The news comes as the global Alzheimer’s Disease Therapeutics Market is experiencing significant growth as an escalating aging population along with earlier and more accurate diagnoses contribute to more people facing the disease.…

Continue Reading